ABOUT US
Menarini Thailand is a member of Menarini Group, the world’s largest Italian biopharmaceutical company with a heritage of over 135 years and over 17,000 employees in more than 140 countries. Menarini Thailand operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to life cycle management with a diverse portfolio of proprietary and partner brands in Consumer Healths, Allergy/Respiraptory, Gastroenterology, Cardio-metabolic, and Aesthetics.
PRODUCT HIGHLIGHT
The innovative XTR™ Technology in hyaluronic acid filler, the new Italian Filler range helps to improve
facial volume distribution and ultimately balances facial contouring.
Our Company History
1886
The “Farmacia Internazionale Menarini” opens in Naples.
1915
Menarini opens its Florence premises.
1964
Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalisation is launched with “Laboratorios Menarini” in Barcelona.
1978
Opening of Menarini Research&Development Division.
Since the 90s
Menarini has expended its international business rapidly.
1992
Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.
2003
Opening of Menarini Biotech in Pomezia (Rome).
2009
Lucia e Alberto Giovanni Aleotti leading Menarini.
2011
Acquisition of the Invida Group consolidating Menarini’s presence in the Asia Pacific markets.
2013
Acquisition of Silicon Biosystems.
2016
CellSearch, pioneer in advanced technologies for cancer diagnostics
2018
The Menarini Group has decided to entrust the Chairmanship of the company to Eric Cornut.
2019
Lucia e Alberto Giovanni Aleotti leading Menarini.
2020
Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market
2021
This year we shall be celebrating the 135th anniversary of the founding of our company.